Codes ATC:
J04BA02
EMLc
Indication
Leprosy
Code ICD11:
1B50.Z
INN
Dapsone
Type de médicament
Chemical agent
Type de liste
Liste de base
(EML)
(EMLc)
(EMLc)
Additional notes
Medicines used in the treatment of leprosy should never be used except in combination. Combination therapy is essential to prevent the emergence of drug resistance. Colour-coded blister packs (MDT blister packs) containing standard two-medicine (paucibacillary leprosy) or three-medicine (multibacillary leprosy) combination for adult and childhood leprosy should be used. MDT blister packs can be supplied free of charge through WHO.
Formulations
Oral > Solid:
100 mg tablet ;
50 mg tablet ;
25 mg tablet
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
Dapsone was endorsed as an essential medicine for children by the EMLc Subcommittee and included on the first EMLc in 2007 for the treatment of leprosy.